alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, the Chief Executive Officer and the Chief Financial Officer of Computer Software Innovations, Inc.
(the Company), each certify, pursuant to 18 USC § 1350 as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350), that to his or her knowledge on the date of this certification:



| | 1. | The quarterly report of the Company for the period ended June 30, 2006 as filed with the Securities and Exchange Commission on this date (the Report) fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------



/s/ Nancy K. HedrickNancy K. HedrickChief Executive OfficerDate: August 14, 2006/s/ David B. DechantDavid B. DechantChief Financial OfficerDate: August 14, 2006
**EXHIBIT 32.2****OSI PHARMACEUTICALS, INC.****CERTIFICATION PURSUANT TO****18 U.S.C. § 1350,****AS ADOPTED PURSUANT TO****SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**    In connection with the Annual Report of OSI Pharmaceuticals,Inc. (the “Company”) onForm 10-K for theyear ended December 31, 2006 as filed with the Securitiesand Exchange Commission on the date hereof (the“Report”), I, Michael G. Atieh, Executive VicePresident and Chief Financial Officer of the Company, certify,pursuant to 18 U.S.C. § 1350, as adopted pursuantto Section 906 of the Sarbanes-Oxley Act of 2002, that:         (1) The Report fully complies with the requirements of    Section 13(a) or 15(d) of the Securities Exchange Act of    1934; and          (2) The information contained in the Report fairly    presents, in all material respects, the financial condition and    result of operations of the Company.     /s/ MICHAEL G. ATIEH       Michael G. Atieh     Executive Vice President and Chief     Financial OfficerDate: February 28, 2007 129
**EXHIBIT31.2**

 

**CERTIFICATION**

 

I, Brian P. Monahan,certify that:

 

1.               I have reviewed this quarterly report on Form 10-Q/Aof Bruker Corporation; and

 

2.               Based on my knowledge, this report does not containany untrue statement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstances underwhich such statements were made, not misleading with respect to the periodcovered by this report.

 

 
| Date: May 25, 2010 | By:    | /s/ Brian P. Monahan                                   |
|-------------------------|--------|--------------------------------------------------------|
|                    |   | Brian P. Monahan                                       |
|                    |   | Chief Financial Officer  (Principal Financial Officer) |

 

----
#### Carl C. REED, Appellant, v. Lillian S. REED, Appellee.

No. 12949.

Court of Civil Appeals of Texas. San Antonio.

Dec. 28, 1955.

*886Joe Burkett, San Antonio, for appellant.

Wilson F. Walters, Denison, Hoyo, Shelton & Haight, San Antonio, for appellee.

POPE, Justice.

This is a suit to change a child custody order. The trial court formerly gave custody to the father but in this suit granted custody of two children, age three and five, to the mother because conditions have materially changed and the best interests and welfare of the children will be served by such a custody order. The judgment is supported by findings of fact.

Appellant, Carl C. Reed, obtained a divorce from Lillian S. Reed, the mother, in May, 1954. She did not answer and the court awarded the children to the father. The mother moved to Colbert, Oklahoma, obtained work and still lives there with her parents. In February, 1955, the father suffered a cerebral condition and voluntarily delivered the children to the mother. The court found that the mother was without funds when she was first separated from the father and when he obtained the custody; that she is now able to care for the children; that the children, when delivered to the mother, were neglected, undernourished and sick, and that they are in a much improved physical condition since the mother has exercised custody. As stated in the appellant’s brief, the trial of the issues was a “swearing match.” In that kind of suit, the trial court’s findings against the appellant left little factual support for this appeal. The trial court did not abuse its discretion. Taylor v. Meek, Tex., 276 S.W.2d 787.

The mother lives with her parents, a short distance beyond the Texas border and works in Texas. The trial court had the power to award custody to one who resides beyond the borders of Texas. Patterson v. Wilson, Tex.Civ.App., 177 S.W.2d 1004; Wrather v. Wrather, Tex.Civ.App., 154 S.W.2d 955; Dickson v. McLaughlan, Tex.Civ.App., 69 S.W.2d 209; Futch v. Futch, Tex.Civ.App., 299 S.W. 289.

The judgment is affirmed.
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-1319]
 AGENCY: Drug Enforcement Administration, Justice.
 ACTION: Notice of application.
 SUMMARY: Patheon API Services Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to 
                        **SUPPLEMENTARY INFORMATION**
                         listed below for further drug information.
 DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 23, 2024. Such persons may also file a written request for a hearing on the application on or before April 23, 2024.
 ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to 
                        *https://www.regulations.gov*
                         and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on 
                        *https://www.regulations.gov.*
                         If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on December 21, 2023, Patheon API Services Inc., 101 Technology Place, Florence, South Carolina 29501, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Controlled substance
Drug code
ScheduleDimethyltryptamine
7435
IPsilocybin
7437
IPsilocyn
7438
IAmphetamine
1100
IIMethadone
9250
II
 The company plans to bulk manufacture the above controlled substances to support customers' clinical trials. No other activities for these drug codes are authorized for this registration. Marsha Ikner, Acting Deputy Assistant Administrator.


[FR Doc. 2024-03686 Filed 2-22-24; 8:45 am] BILLING CODE P
Sorption to soils/sediments = v.strong

PBT Potential: PMN P3B1; Deg Pdt P3B2

*CEB FATE: Migration to ground water = negl

 Health:

 Health Summary: Absorption is nil all routes based on physical/chemical 

properties. There is concern for lung effects if respirable particles are inhaled from lung overload 

associated with high molecular weight polymers and from waterproofing of the 

lungs. 

For the potential incomplete incineration product, based on test data for the analogue 

perfluorohexanoic acid concerns are liver toxicity, blood toxicity, and male reproductive toxicity 

[rat 28-day oral NOAEL = 50 mg/kg, LOAEL = 150 mg/kg with liver toxicity; rat 90-day oral 

LOAEL = 10 mg/kg based on decreased body weight in males at all doses and liver toxicity and 

anemia at 200 mg/kg; there were toxic effects on the testes in 2 males in the 90-day oral study 

that were judged by the reviewer to be indicative of the potential for male reproductive toxicity. 

There is also concern for immunosuppression and oncogenicity based on data for PFOA and 

PFOS.

 Test Data: (+) mild irritant to rabbit eyes; (-) skin irritation; (-) not 

sensitizing in a mouse local lymph node assay; acute oral rat LD50 > 2000 mg/kg bw.

 Ecotox:

Test 

Organism

Test 

Type

Test End 

Point

Predicted Measured Comments

fish 96-h LC50 *

daphnid 48-h LC50 *

green algal 96-h EC50 *

fish _ chronic 

value

*

daphnid _ chronic 

value

*

algal _ chronic 

value

*

Sewage 

Sludge

3-h EC50 _

Sewage 

Sludge

_ Chronic 

Value

_

Ecotox Values Comments: Predictions are based on SARs for nonionic polymers; SAR 

chemical class = polymer-nonionic-(meth)acrylate-perFC6; MW 10,000 with 0.8% < 1000 and 

0.4% < 500; solid; S < 0.001 mg/L at 25 C (P); pH7; effective concentrations based on 100% 

active ingredients and nominal concentrations; hardness <150.0 mg/L as CaCO3; and TOC 

<2.0 mg/L;
#### CONNECTICUT STATE EMPLOYEES ASSOCIATION *v.*DEPARTMENT OF HOUSING ET AL.

(14325)

O’Connell, Schaller and Santaniello, Js.

Argued January 9

decision released January 30, 1996

*Robert J. Krzys,*for the appellant (plaintiff).

*Maria C. Rodriguez,*assistant attorney general, with whom, on the brief, were *Richard Blumenthal,*attorney general, and *Charles A. Overend,*assistant attorney general, for the appellees (defendants).

PER CURIAM.

The judgment is affirmed.
Docket No. FAA-2012-0106
##### 



Exhibit 10.39
 
 st
  Scientific Advisory Board and Consulting
Agreement, dated as of 10 th February 2006
between Prosidion Limited and Dr Daryl Granner (the Agreement)
 st st
  SIGNED for and on behalf of:PROSIDION LIMITEDBy:
    
    /s/ Anker Lundemose

                (Signature)Dr. A. Lundemose

                (Name Printed)1st January 2008(Date)ACCEPTED AND AGREED:DR DARYL GRANNERBy:
    
    /s/ Darryl K. Granner

                (Signature)Daryl K. Granner

                (Name Printed)1-09-08

               (Date)
[Federal Register Volume 89, Number 36 (Thursday, February 22, 2024)]
[Notices]
[Page 13385]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03633]


-----------------------------------------------------------------------

POSTAL SERVICE


International Product Change--Priority Mail Express 
International, Priority Mail International & Commercial ePacket 
Agreement

AGENCY: Postal Service<SUP>TM</SUP>.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Postal Service gives notice of filing a request with the 
Postal Regulatory Commission to add a Priority Mail Express 
International, Priority Mail International & Commercial ePacket 
contract to the list of Negotiated Service Agreements in the 
Competitive Product List in the Mail Classification Schedule.

DATES: Date of notice: February 22, 2024.

FOR FURTHER INFORMATION CONTACT: Christopher C. Meyerson, (202) 268-
7820.

SUPPLEMENTARY INFORMATION: The United States Postal Service[supreg] 
hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on 
February 7, 2024, it filed with the Postal Regulatory Commission a USPS 
Request to Add Priority Mail Express International, Priority Mail 
International & Commercial ePacket Contract 4 to Competitive Product 
List. Documents are available at www.prc.gov, Docket Nos. MC2024-186 
and CP2024-192.

Colleen Hibbert-Kapler,
Attorney, Ethics and Legal Compliance.
[FR Doc. 2024-03633 Filed 2-21-24; 8:45 am]
BILLING CODE 7710-12-P
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               JUN-30-2000
<CASH>                                         291,000
<SECURITIES>                                   333,000
<RECEIVABLES>                                  175,000
<ALLOWANCES>                                 (159,000)
<INVENTORY>                                    203,000
<CURRENT-ASSETS>                             1,002,000
<PP&E>                                         531,000
<DEPRECIATION>                                 478,000
<TOTAL-ASSETS>                               1,683,000
<CURRENT-LIABILITIES>                       15,534,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                    420,000
<COMMON>                                       507,000
<OTHER-SE>                                (14,778,000)
<TOTAL-LIABILITY-AND-EQUITY>                 1,683,000
<SALES>                                      1,634,000
<TOTAL-REVENUES>                             2,547,000
<CGS>                                        2,346,000
<TOTAL-COSTS>                               15,031,000
<OTHER-EXPENSES>                           (1,714,000)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                         (1,853,000)
<INCOME-PRETAX>                           (14,198,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (14,198,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (14,198,000)
<EPS-BASIC>                                     (0.20)
<EPS-DILUTED>                                   (0.20)


</TABLE>
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

                                                              EXHIBIT 27     


<ARTICLE> 5

<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
REGISTRANT'S FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 1995 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
INCLUDED IN SUCH REPORT.
</LEGEND>


       
<S>                     <C>
<PERIOD-TYPE>           12-MOS
<FISCAL-YEAR-END>       DEC-31-1995
<PERIOD-END>            DEC-31-1995

<CASH>                           1,391,904 
<SECURITIES>                          0    
<RECEIVABLES>                        6,421 
<ALLOWANCES>                          0    
<INVENTORY>                           0    
<CURRENT-ASSETS>                 1,398,325 
<PP&E>                                0    
<DEPRECIATION>                        0    
<TOTAL-ASSETS>                   2,077,801 
<CURRENT-LIABILITIES>               11,144 
<BONDS>                               0    
<COMMON>                              0    
<PREFERRED-MANDATORY>                 0    
<PREFERRED>                           0    
<OTHER-SE>                       2,066,657 
<TOTAL-LIABILITY-AND-EQUITY>     2,077,801 
<SALES>                               0    
<TOTAL-REVENUES>                   552,394 
<CGS>                                 0    
<TOTAL-COSTS>                         0    
<OTHER-EXPENSES>                   211,451 
<LOSS-PROVISION>                      0    
<INTEREST-EXPENSE>                    0    
<INCOME-PRETAX>                    340,943 
<INCOME-TAX>                          0    
<INCOME-CONTINUING>                386,999 
<DISCONTINUED>                        0    
<EXTRAORDINARY>                       0    
<CHANGES>                             0    
<NET-INCOME>                       386,999 
<EPS-PRIMARY>                         4.18 
<EPS-DILUTED>                         4.18 

        


</TABLE>
**Exhibit
      32.1**








**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the amendment to the Annual Report of Capital Gold Corporation
      (the “Company”) on Form 10-KSB for the fiscal year ended July 31, 2006 as filed
      with the Securities and Exchange Commission on the date hereof (the “Report”),
      I, Gifford A. Dieterle, Chief Executive Officer of the Company, certify,
      pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley
      Act of 2002, that:





(1)
      The Report fully complies with the requirements of section 13(a) or 15(d) of
      the
      Securities Exchange Act of 1934; and





(2)
      The information contained in the Report fairly presents, in all material
      respects, the financial condition and result of operations of the
      Company.





/s/
              Gifford A.
              DieterleGifford
                A. Dieterle
              Chief
                Executive Officer
              March
                16, 2007
EXHIBIT 10.14


 


Director Compensation Arrangements



 


Annual compensation to consist of cash fees
of $20,000 to be paid in quarterly increments, and a grant of stock options with a value of $25,000 at the grant date, which shall
be the fifth business day following the Corporation’s annual stockholders meeting, with all such awards to vest in full in
equity quarterly increments over a period of one year from the grant date.


 


In addition, all non-employee directors
shall be reimbursed for their expenses incurred in connection with attending Board and Committee meetings.
EXHIBIT 32.2

CERTIFICATION PURSUANT TO18 U.S.C. §1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Enzon Pharmaceuticals, Inc. (the Company) on Form 10-K for the year ended December 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Craig A. Tooman, Executive Vice President, Finance and Chief Financial Officer of the Company,
  certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

|  
|--
|1.
|  
|2.

|              |  |                                                                                                                             |  | 
|------------- |  | --------------------------------------------------------------------------------------------------------------------------- |  | 
|March 6, 2009 |  | /s/ Craig A. ToomanCraig A. ToomanExecutive Vice President,Finance and Chief Financial Officer(Principal Financial Officer) |  | 

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to Enzon Pharmaceuticals, Inc. and will be furnished to the Securities Exchange Commission or its staff upon request.



---
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in Local Rule

47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 95-50642

Summary Calendar

 

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

ALBERT SANCHEZ, JR.,

Defendant-Appellant.

- - - - - - - - - -

Appeal from the United States District Court

for the Western District of Texas

USDC No. SA-94-CR-384

- - - - - - - - - -

June 3, 1997

Before KING, JOLLY and DENNIS, Circuit Judges.

PER CURIAM:*

Albert Sanchez, Jr., appeals his sentence after being

convicted of distribution of cocaine and possession of cocaine

with intent to distribute. Sanchez contends that the district

court erred in assessing a two-level enhancement under U.S.S.G. 

§ 3B1.1(c) after determining that he was an organizer in the

offense. We have reviewed the record and the briefs of the

parties and hold that the district court’s determination did not
No. 95-50642

- 2 -

have an adequate evidentiary basis. United States v. Jobe, 101

F.3d 1046 (5th Cir. 1996). The record is inadequate to show that

Sanchez supervised Manzano in any activity for which Manzano was

criminally liable. Accordingly, the two-level enhancement under

§ 3B1.1(c) was improper. 

It is ordered that the sentence imposed by the district

court against Sanchez is VACATED. The case is REMANDED to the

district court for resentencing. 

VACATED AND REMANDED.
Exhibit 99.2







CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002,

18 U.S.C. SECTION 1350

I, Emanuel Chirico, Executive Vice President and Chief Financial Officer of Phillips-Van Heusen Corporation (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1)  the Quarterly Report on Form 10-Q for the quarterly period ended August 3, 2003 (the "Periodic Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. Section 78m or 78o(d)); and

(2)  the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

|Dated: September 15, 2003 | /s/ Emanuel Chirico
|------------------------- | -------------------

Emanuel Chirico

Executive Vice President and

Chief Financial Officer
#### ROBERTO NUNEZ *v.*EARL ABRAMS ET AL.

(14745)

Foti, Heiman and SchaUer, Js.

Submitted on briefs February 22

decision released March 26, 1996

*Joseph M. Brophy*filed a brief for the appellant (plaintiff).

*Carolyn P. Gould*and *David J. Crotta, Jr.,*filed a brief for the appellees (defendants).

PER CURIAM.

The judgment is affirmed.